Vivos Therapeutics, Inc. (VVOS) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 15 transactions totaling $136.2K, demonstrating a bullish sentiment with $136.2K in net insider flow. The most recent transaction on Jun 20, 2023 involved a purchase of 14,000 shares valued at $7.4K.
No significant insider buying has been recorded for VVOS in the recent period.
No significant insider selling has been recorded for VVOS in the recent period.
Based on recent SEC filings, insider sentiment for VVOS is bullish with an Insider Alignment Score of 100/100 and a net flow of $136.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Vivos Therapeutics, Inc. (VVOS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading VVOS stock, having executed 15 transactions in the past 90 days. The most active insider is Ronald Kirk Huntsman (Executive), who has made 12 transactions totaling $116.3K.
Get notified when executives and directors at VVOS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Kirk Huntsman Ronald | Executive | Purchase | 14,000 | $0.53 | $7.4K | |
| Jun 16, 2023 | Kirk Huntsman Ronald | Executive | Purchase | 10,000 | $0.54 | $5.4K | |
| Jun 16, 2023 | Kirk Huntsman Ronald | Executive | Purchase | 5,000 | $0.53 | $2.6K | |
| Jun 15, 2023 | Kirk Huntsman Ronald | Executive | Purchase | 21 | $0.50 | $11 | |
| Jun 14, 2023 | Kirk Huntsman Ronald | Executive | Purchase | 10,000 | $0.49 | $4.9K | |
| Dec 23, 2022 | Kirk Huntsman Ronald | Executive | Purchase | 20,000 | $0.50 | $10.0K | |
| Jun 1, 2022 | Kirk Huntsman Ronald | Executive | Purchase | 4,000 | $1.83 | $7.3K | |
| May 31, 2022 | Kirk Huntsman Ronald | Executive | Purchase | 8,000 | $2.03 | $16.2K | |
| Sep 21, 2021 | Kirk Huntsman Ronald | Executive | Purchase | 5,000 | $4.31 | $21.6K | |
| Aug 17, 2021 | Kirk Huntsman Ronald | Executive | Purchase | 5,000 | $3.00 | $15.0K | |
| May 25, 2021 | Kirk Huntsman Ronald | Executive | Purchase | 4,000 | $5.38 | $21.5K | |
| May 25, 2021 | K. Amman Bradford | Executive | Purchase | 1,000 | $5.29 | $5.3K | |
| Dec 24, 2020 | K. Amman Bradford | Executive | Purchase | 1,000 | $7.38 | $7.4K | |
| Dec 23, 2020 | Unknown | Executive | Purchase | 1,000 | $7.27 | $7.3K | |
| Dec 11, 2020 | Kirk Huntsman Ronald | Executive | Purchase | 500 | $8.50 | $4.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $136.2K | 100.0% |
Insiders at Vivos Therapeutics, Inc. are accumulating shares at an accelerated pace. With 2 insiders making 15 transactions totaling $136.2K in purchases versus $0 in sales, the net buying activity of $136.2K signals strong executive confidence. Ronald Kirk Huntsman (Executive) leads the buying activity with $116.3K in transactions across all time.